Sep 22, 2026 09:02AM
Sep 22, 2026 09:00AM
Sep 14, 2026 09:01AM
Sep 14, 2026 09:00AM
Aug 27, 2026 02:00AM
Aug 27, 2026 02:00AM
Aug 21, 2026 11:58AM FTC files amicus brief challenging Amgen's Enbrel patent acquisition
Aug 4, 2026 04:01PM
Jul 30, 2026 04:01PM
Jun 24, 2026 06:00AM
Jun 24, 2026 06:00AM
Jun 9, 2026 04:38PM
Jun 8, 2026 02:56AM
Jun 7, 2026 04:45PM AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
Jun 3, 2026 09:01AM
Jun 3, 2026 09:00AM
May 19, 2026 04:05PM
May 19, 2026 04:05PM
May 13, 2026 08:30AM
May 11, 2026 08:30AM
May 4, 2026 09:01AM AMGEN announces $300 million US manufacturing investment
May 4, 2026 09:00AM
Apr 30, 2026 04:01PM
Apr 30, 2026 04:01PM
Apr 22, 2026 04:00PM
Apr 22, 2026 04:00PM
Apr 6, 2026 09:00AM
Apr 6, 2026 09:00AM AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
Apr 2, 2026 08:07AM
Mar 28, 2026 04:45PM
Mar 4, 2026 04:01PM
Feb 3, 2026 04:01PM
Jan 6, 2026 09:28AM
Jan 6, 2026 09:01AM
Jan 6, 2026 09:00AM AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE
Dec 19, 2025 02:24PM
Dec 19, 2025 02:23PM
Dec 11, 2025 06:10PM
Dec 11, 2025 06:09PM
Dec 9, 2025 04:01PM
Nov 25, 2025 05:07AM
Nov 19, 2025 04:02PM FDA grants full approval for Amgen's IMDELLTRA in lung cancer
Nov 19, 2025 04:01PM
Nov 8, 2025 10:15AM
Nov 8, 2025 10:15AM
Nov 4, 2025 04:01PM
Oct 31, 2025 04:01PM
Oct 31, 2025 09:00AM
Oct 31, 2025 09:00AM AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025
Oct 17, 2025 04:00PM

1,192,372 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All